DVA (STOCKS)
DaVita Inc.
$151.560000
+1.510000 (+1.01%)
Prev close: $150.050000
Company Information
- Exchange
- XNYS
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- CEO
- Javier J. Rodriguez
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $10,127.21M
- Employees
- 76,000
- P/E (TTM)
- 15.78
- P/B (TTM)
- -15.96
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
1
Strong Buy
5
Buy
7
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$3.40 | $3.19 | +0.2129 | +6.68% |
|
Sep 2025 (Q3)
|
$2.04 | $3.25 | -1.2142 | -37.31% |
|
Jun 2025 (Q2)
|
$2.95 | $2.83 | +0.1181 | +4.17% |
|
Mar 2025 (Q1)
|
$2.00 | $1.97 | +0.0329 | +1.67% |
Financial Statements
| Revenues | $13.64B |
| Benefits Costs and Expenses | $12.30B |
| Costs And Expenses | $11.60B |
| Operating Expenses | $11.60B |
| Depreciation and Amortization | $715.35M |
| Other Operating Expenses | $10.88B |
| Operating Income/Loss | $2.04B |
| Income/Loss Before Equity Method Investments | $1.31B |
| Income/Loss From Continuing Operations After Tax | $1.05B |
| Income/Loss From Continuing Operations Before Tax | $1.35B |
| Income/Loss From Discontinued Operations Net Of Tax | $25.00M |
| Income/Loss From Equity Method Investments | $33.00M |
| Income Tax Expense/Benefit | $293.11M |
| Income Tax Expense/Benefit, Current | $206.54M |
| Income Tax Expense/Benefit, Deferred | $86.57M |
| Interest And Debt Expense | $579.93M |
| Net Income/Loss | $1.08B |
| Net Income/Loss Attributable To Noncontrolling Interest | $331.91M |
| Net Income/Loss Attributable To Parent | $746.80M |
| Net Income/Loss Available To Common Stockholders, Basic | $746.80M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $10.06 |
| Diluted Earnings Per Share | $9.84 |
| Basic Average Shares | 74,227,000 |
| Diluted Average Shares | 75,885,000 |
| Assets | $17.48B |
| Current Assets | $4.06B |
| Inventory | $160.63M |
| Other Current Assets | $3.90B |
| Noncurrent Assets | $13.42B |
| Fixed Assets | $2.81B |
| Intangible Assets | $222.13M |
| Other Non-current Assets | $10.39B |
| Liabilities | $16.32B |
| Current Liabilities | $3.14B |
| Accounts Payable | $696.15M |
| Wages | $793.48M |
| Other Current Liabilities | $1.65B |
| Noncurrent Liabilities | $13.18B |
| Redeemable Noncontrolling Interest | $1.53B |
| Equity | -$373.73M |
| Equity Attributable To Noncontrolling Interest | $277.35M |
| Equity Attributable To Parent | -$651.08M |
| Temporary Equity | $1.53B |
| Liabilities And Equity | $17.48B |
| Net Cash Flow From Operating Activities | $1.89B |
| Net Cash Flow From Operating Activities, Continuing | $1.89B |
| Net Cash Flow From Investing Activities | -$654.95M |
| Net Cash Flow From Investing Activities, Continuing | -$654.95M |
| Net Cash Flow From Financing Activities | -$1.37B |
| Net Cash Flow From Financing Activities, Continuing | -$1.37B |
| Net Cash Flow | -$143.23M |
| Net Cash Flow, Continuing | -$143.23M |
| Comprehensive Income/Loss | $1.27B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $331.91M |
| Comprehensive Income/Loss Attributable To Parent | $934.82M |
| Other Comprehensive Income/Loss | $188.01M |